Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-29

FDA Approved: DARUNAVIR — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' original ANDA for darunavir, establishing a generic version of the HIV-1 protease inhibitor for use in combination antiretro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir (darunavir)

Snippet

ORIG AP for DARUNAVIR (DARUNAVIR)